8x8 Vs. Halozyme Therapeutics Industry Stock Comparison

Buy

58

EGHT
8x8

Last Price:

2.82

Seasonality Move:

14.28%

Sell

39

HALO
Halozyme Therapeutics

Last Price:

45.65

Seasonality Move:

17.03%

Buy

58

8x8 (EGHT) is a Buy

Is 8x8 a Buy, Sell or Hold?

The current 8x8 [EGHT] share price is $2.81. The Score for EGHT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
EGHT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

39

Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EGHT Stock Price Chart

What is 8x8's stock price today?

The 8x8 share price today is $2.81
The current trend is moderately bullish and EGHT is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

The Halozyme Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EGHT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.24	Buy
Relative Strength Index (14 RSI):	69.63	Buy
Chaikin Money Flow:	-194593	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.98 - 2.76)	Buy
Bollinger Bands (100):	(1.76 - 2.68)	Buy

HALO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	30.2	Sell
Chaikin Money Flow:	-7140517	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(49.94 - 58.56)	Sell
Bollinger Bands (100):	(52.16 - 60.38)	Sell

EGHT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	2.89	Sell
20-day SMA:	2.45	Buy
50-day SMA:	2.14	Buy
200-day SMA:	2.4	Buy
8-day EMA:	2.79	Buy
20-day EMA:	2.55	Buy
50-day EMA:	2.3	Buy
200-day EMA:	2.48	Buy

HALO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	57.53	Sell
20-day SMA:	54.48	Sell
50-day SMA:	56.18	Sell
200-day SMA:	48.93	Sell
8-day EMA:	55	Sell
20-day EMA:	55.41	Sell
50-day EMA:	55.64	Sell
200-day EMA:	50.73	Sell

8x8 Earnings Growth & EGHT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.12 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

8x8 Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):